THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Theophylline 0.4% And Dextrose 5% In Plastic Container patents expire, and when can generic versions of Theophylline 0.4% And Dextrose 5% In Plastic Container launch?
Theophylline 0.4% And Dextrose 5% In Plastic Container is a drug marketed by B Braun and is included in two NDAs.
The generic ingredient in THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Theophylline 0.4% And Dextrose 5% In Plastic Container
A generic version of THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER was approved as theophylline by RHODES PHARMS on September 1st, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER?
- What are the global sales for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| Clinical Trials: | 111 |
| DailyMed Link: | THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tanta University | N/A |
| LG Chem | Phase 1 |
| University of Oklahoma | Phase 1/Phase 2 |
See all THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER clinical trials
US Patents and Regulatory Information for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | theophylline | INJECTABLE;INJECTION | 019212-003 | Nov 7, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| B Braun | THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | theophylline | INJECTABLE;INJECTION | 019212-002 | Nov 7, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| B Braun | THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | theophylline | INJECTABLE;INJECTION | 019826-005 | Aug 14, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
